Author:
Ranganath Praveen Ganti,Robbin Michelle L.,Back Susan J.,Grant Edward G.,Fetzer David T.
Publisher
Springer Science and Business Media LLC
Subject
Urology,Gastroenterology,Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Reference52 articles.
1. Mattrey RF, Scheible FW, Gosink BB, et al. (1982) Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material. Radiology 145(3):759–762.
https://doi.org/10.1148/radiology.145.3.7146409
2. Mattrey RF, Strich G, Shelton RE, et al. (1987) Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: preliminary clinical results. Radiology 163(2):339–343.
https://doi.org/10.1148/radiology.163.2.3550878
3. First Approval by U.S. Food and Drug Administration for Contrast Enhanced Ultrasonography of the Liver Received by Bracco Diagnostics Inc. for LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use (2016). Bracco Diagnostics Inc., Monroe Township
4. ACR Committee on Drugs and Contrast Media (2016) ACR manual on contrast media v10.2. ACR website.
https://www.acr.org/Clinical-Resources/Contrast-Manual
. Accessed 20 Sep 2017
5. Benozzi L, Cappelli G, Granito M, et al. (2009) Contrast-enhanced sonography in early kidney graft dysfunction. Transplant Proc 41(4):1214–1215.
https://doi.org/10.1016/j.transproceed.2009.03.029
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献